SEC Form 4 · accession 0001022079-17-000180
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Stanzione
Director
Period of report
Sep 11, 2017
Accepted (ET)
Sep 13, 2017 · 6:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 11, 2017 | M | 7,316 | $51.55 | A | 41,991 | D | |
| Common Stock | Sep 11, 2017 | M | 7,319 | $55.76 | A | 49,310 | D | |
| Common Stock | Sep 11, 2017 | M | 5,592 | $57.665 | A | 54,902 | D | |
| Common Stock | Sep 11, 2017 | M | 4,268 | $57.565 | A | 59,170 | D | |
| Common Stock | Sep 11, 2017 | M | 5,221 | $61.225 | A | 64,391 | D | |
| Common Stock | Sep 11, 2017 | M | 5,592 | $57.565 | A | 69,983 | D | |
| Common Stock | Sep 11, 2017 | M | 5,592 | $61.225 | A | 75,575 | D | |
| Common Stock | Sep 11, 2017 | S | 40,900 | $108.067 | D | 34,675 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $51.55 | Sep 11, 2017 | M | 7,316 | D | — | May 14, 2019 | Common Stock | 7,316 | 0 | D |
| Stock Options (Right to Buy)F3 | $55.76 | Sep 11, 2017 | M | 7,319 | D | — | May 6, 2020 | Common Stock | 7,319 | 0 | D |
| Stock Options (Right to Buy)F4 | $57.665 | Sep 11, 2017 | M | 5,592 | D | — | May 17, 2021 | Common Stock | 5,592 | 0 | D |
| Non-Qualifed Stock Option (right to buy)F5 | $57.565 | Sep 11, 2017 | M | 5,592 | D | — | May 11, 2022 | Common Stock | 5,592 | 0 | D |
| Stock Options (Right to Buy)F5 | $57.565 | Sep 11, 2017 | M | 4,268 | D | — | May 11, 2022 | Common Stock | 4,268 | 0 | D |
| Non-Qualifed Stock Option (right to buy)F6 | $61.225 | Sep 11, 2017 | M | 5,592 | D | — | May 21, 2023 | Common Stock | 5,592 | 0 | D |
| Stock Options (Right to Buy)F6 | $61.225 | Sep 11, 2017 | M | 5,221 | D | — | May 21, 2023 | Common Stock | 5,221 | 0 | D |
Explanation of responses
- F1This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.
- F2The options vested in three annual installments beginning with the first on May 14, 2010, the second on May 14, 2011 and the final on May 14, 2012.
- F3The options vested in three annual installments beginning with the first on May 16, 2011, the second on May 6, 2012 and the final on May 6, 2013.
- F4The options vested in three annual installments beginning with the first on May 17, 2012, the second on May 17, 2013 and the final on May 17, 2014.
- F5The options vested in three annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015.
- F6The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016.